|
|
Post by notamnkdmillionaire on Apr 23, 2015 17:25:53 GMT -5
|
|
|
|
Post by ripano on Apr 23, 2015 19:25:58 GMT -5
In my humble opinion, I have posted several times that the so called "shorts" are actually also buyers accumulating shares at very cheap levels. They will do this as long as possible until some sort of catalyst of good news is announced. At that time call options will be used to unwind this trade. It is very encouraging to see call options starting to accumulate, we may finally start to see the true potential of this Blockbuster drug. When institutional records are released this quarter we will know if the shorts were actually Buyers also.
|
|
|
|
Post by orlon on Apr 23, 2015 20:30:45 GMT -5
I don't dabble in option either but just read the article dated 4/23/15. According to the writer, Ellen Gold, Mannkind is still waiting for approval by FDA. Difficult to trust an article if it is not sufficiently researched.
|
|
